Prism Medico No NCS Payable Q1 FY27

Prism Medico and Pharmacy Ltd filed an intimation under SEBI LODR Regulation 57(4) with BSE and MSEI.
The company confirms no non-convertible securities with interest/dividend/principal due in Q1 FY27 (April–June 2026).
Disclosure signed by Director Davender Singh (DIN: 09447213) and dated 30th March 2026.